Ignite Creation Date:
2025-12-24 @ 10:03 PM
Ignite Modification Date:
2025-12-30 @ 5:50 PM
Study NCT ID:
NCT01205035
Status:
COMPLETED
Last Update Posted:
2015-04-10
First Post:
2010-09-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
High-Dose Lucentis (Ranibizumab 2.0mg) for the Treatment of Nonproliferative Idiopathic Parafoveal Telangiectasia
Sponsor:
Eye Center of Northern Colorado, P.C.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-10
Start Date Type:
None
Primary Completion Date:
2012-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-10
Completion Date Type:
ACTUAL
First Submit Date:
2010-09-16
First Submit QC Date:
None
Study First Post Date:
2010-09-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-03-18
Results First Submit QC Date:
None
Results First Post Date:
2015-04-10
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-03-30
Last Update Post Date:
2015-04-10
Last Update Post Date Type:
ESTIMATED